Sarissa Capital Management logo

Sarissa Capital Management

North America, Connecticut, United States, Greenwich

Description

Sarissa Capital Management is an investment Firm.

Investor Profile

Sarissa Capital Management has backed more than 6 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 33% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Post Ipo Equity, Series D rounds (top funding stages).
  • Majority of deals are located in United States, Ireland.
  • Strong thematic focus on Biotechnology, Pharmaceutical, Health Care.

Stage Focus

  • Series B (33%)
  • Post Ipo Equity (33%)
  • Series D (17%)
  • Series E (17%)

Country Focus

  • United States (83%)
  • Ireland (17%)

Industry Focus

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Therapeutics
  • Biopharma
  • Mhealth
  • Software
  • Clinical Trials
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Sarissa Capital Management frequently co-invest with?

venBio Partners
North America, California, United States, San Francisco
Co-Investments: 2
Surveyor Capital
North America, Illinois, United States, Chicago
Co-Investments: 2
5AM Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Pilot House Ventures
North America, Massachusetts, United States, Boston
Co-Investments: 2
QUAD Investment Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2
Vivo Capital
North America, California, United States, Palo Alto
Co-Investments: 2
Logos Capital
North America, California, United States, San Francisco
Co-Investments: 2
FM
Europe, Stirling, United Kingdom, Stirling
Co-Investments: 2
Jazz Venture Partners
North America, California, United States, San Francisco
Co-Investments: 2
Arboretum Ventures
North America, Michigan, United States, Ann Arbor
Co-Investments: 2

What are some of recent deals done by Sarissa Capital Management?

Attralus

San Francisco, California, United States

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

BiopharmaBiotechnologyHealth CareMedical
Series BFeb 6, 2024
Amount Raised: $56,000,000
Lyndra Therapeutics

Watertown, Massachusetts, United States

Lyndra Therepeutics creates therapies for long-term drug release in an oral dose form.

BiotechnologyClinical TrialsHealth CarePharmaceutical
Series EDec 21, 2023
Amount Raised: $101,000,000
Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Post Ipo EquityDec 6, 2021
Amount Raised: $125,000,000
Attralus

San Francisco, California, United States

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

BiopharmaBiotechnologyHealth CareMedical
Series BSep 8, 2021
Amount Raised: $116,000,000
Pear Therapeutics

Boston, Massachusetts, United States

Pear Therapeutics is a software-based digital therapeutics platform designed to treat disease and enhance the efficacy of pharmaceuticals.

BiotechnologymHealthPharmaceuticalSoftwareTherapeutics
Series DDec 8, 2020
Amount Raised: $80,000,000
Iterum Therapeutics

Dublin, Dublin, Ireland

Iterum Therapeutics is a clinical-stage pharmaceutical company that develops significantly differentiated anti-infectives.

MedicalPharmaceuticalTherapeutics
Post Ipo EquityJan 17, 2020
Amount Raised: $51,900,000

Find More Investors Like Sarissa Capital Management

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

Sarissa Capital Management | Pipeseed